Easterly Investment Partners’s Collegium Pharmaceutical COLL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.22M	Buy	37,231 +2,100	+6%	+$88.9K	0.09%	109
2025 Q4	$1.63M	Sell	35,131 -16,281	-32%	-$681K	0.1%	133
2025 Q3	$1.8M	Sell	51,412 -1,000	-2%	-$34.8K	0.12%	123
2025 Q2	$1.55M	Sell	52,412 -3,746	-7%	-$107K	0.11%	126
2025 Q1	$1.68M	Hold	56,158	–	–	0.14%	119
2024 Q4	$1.61M	Hold	56,158	–	–	0.13%	128
2024 Q3	$2.17M	Buy	56,158 +13,529	+32%	+$482K	0.17%	108
2024 Q2	$1.37M	Sell	42,629 -7,000	-14%	-$243K	0.12%	133
2024 Q1	$1.93M	Sell	49,629 -22	-0%	-$770	0.15%	123
2023 Q4	$1.53M	Hold	49,651	–	–	0.16%	121
2023 Q3	$1.11M	Hold	49,651	–	–	0.12%	129
2023 Q2	$1.07M	Buy	49,651 +24,622	+98%	+$559K	0.1%	140
2023 Q1	$600K	Buy	25,029 +3,000	+14%	+$79.6K	0.05%	155
2022 Q4	$511K	Hold	22,029	–	–	0.04%	155
2022 Q3	$353K	Hold	22,029	–	–	0.03%	164
2022 Q2	$390K	Sell	22,029 -2,000	-8%	-$33.6K	0.03%	159
2022 Q1	$489K	Buy	+24,029	New	+$454K	0.04%	162